StreetInsider.com News Articles

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Biotech Insider News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Form 8-K Organogenesis Holdings For: Jun 15

Tue, 16 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260616/26654595.html

Form 8-K Organogenesis Holdings For: Jun 15

Tue, 16 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260616/26654595.html

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

Truist Securities Starts Oranogenesis Holdings (ORGO) at Hold

Thu, 28 May 2026 06:06:05 -0400

Truist Securities analyst Ravi Misra initiates coverage on Oranogenesis Holdings (NASDAQ: ORGO) with a Hold rating and a price target of $3.00.

The analyst comments "Initiating with HOLD and $3 PT on ORGO, a leader in skin substitutes in the wound care market. Reimbursement changes are driving structural shifts across care settings in '26, and impacting all players as stakeholders navigate a new payment paradigm. A shakeout in the space could benefit ORGO as smaller players exit the market due to unfavorable economics, but we see limited NT rev upside (recently lowered guidance contemplates a worse decline in '26 than prior).